Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / By country / Switzerland

Peptide legality · Switzerland · updated 2026-09-23

Are peptides legal in Switzerland?

Restricted

Peptides are legal in Switzerland only as medicines authorised by Swissmedic and dispensed on prescription; unapproved 'research' peptides such as BPC-157 and TB-500 are not authorised and cannot be lawfully sold or marketed for human use, although a private individual may personally import a one-month supply of a prescribed medicine.

Legal status overview

Peptides are lawful in Switzerland only when they are medicinal products authorised by Swissmedic and supplied through licensed medical channels, generally on prescription. Under the Therapeutic Products Act, Swissmedic must authorise and classify every medicine before it can be marketed, and prescription-only categories (A and B) require a doctor's prescription. Prescription peptide drugs for diabetes, obesity, cancer and hormonal disorders are legally available, but unapproved peptides sold online as powders or 'research chemicals' are not authorised medicines and cannot be lawfully sold for human use.

Key points

  • Peptides are legal in Switzerland only as authorised medicines supplied through licensed channels, with prescription peptide drugs for diabetes, weight loss, certain cancers and hormonal disorders being lawfully available. [1]
  • In Switzerland, a medicinal product may only be placed on the market once Swissmedic has authorised it, and Swissmedic then classifies each medicine into a dispensing category. [2]
  • Under Swiss therapeutic-products law, prescription-only medicines fall into dispensing categories A and B, which require a doctor's prescription to obtain. [3]
  • Swissmedic has approved the GLP-1/weight-loss injection class in Switzerland, with liraglutide, semaglutide and tirzepatide authorised as prescription 'weight-loss injections'. [4]
  • For personal importation into Switzerland, private individuals (including tourists) may import a one-month supply of a medicine for their own use but not on behalf of third parties. [6]
  • Medicines classified as narcotics face stricter Swiss import controls and may only be imported or exported under additional conditions, beyond the standard one-month personal-supply rule. [6]
  • Unapproved peptides sold as powders, pills or 'research chemicals' are not authorised medicines in Switzerland and therefore cannot be lawfully sold or marketed for human use. [1]

Compound-by-compound status

BPC-157BPC-157 is not an authorised medicine in Switzerland and falls in the unapproved 'research peptide' category that cannot be lawfully sold or marketed for human use, and it is additionally banned in sport under WADA rules. [10]
Semaglutide (GLP-1, weight-loss/diabetes)Semaglutide is a Swissmedic-authorised, prescription-only medicine in Switzerland, with the diabetes product (Ozempic®) usable for weight loss only via off-label prescription and a dedicated obesity product (Wegovy®) also available on prescription. [5]
Tirzepatide (GLP-1/GIP)Tirzepatide is approved by Swissmedic in Switzerland as one of the authorised prescription 'weight-loss injections' alongside liraglutide and semaglutide. [4]
TB-500 (thymosin beta-4)TB-500 has no Swissmedic authorisation and falls within the same unapproved research-peptide category that cannot be lawfully sold as a medicine for human use in Switzerland; no Switzerland-specific statute naming TB-500 was located. [1]
Human growth hormone (HGH/somatropin)Somatropin is regulated in Switzerland as a prescription-only medicine obtainable through the authorised, prescription-based Swissmedic framework; no HGH-specific Swiss source was located in this research, so this reflects the general prescription-medicine framework rather than a compound-specific citation. (no source found)

Frequently asked questions

Can I buy peptides in Switzerland without a prescription?

No, authorised peptide medicines in Switzerland (dispensing categories A and B) require a doctor's prescription, and unapproved 'research' peptides sold online are not authorised medicines and cannot be lawfully sold for human use. [3]

Can I bring peptides into Switzerland for personal use?

Yes, but only within limits: a private individual (including a tourist) may import a one-month supply of a medicine for their own personal use and not for third parties, with stricter rules applying to any medicine classified as a narcotic. [6]

Are weight-loss peptides like Ozempic® and Wegovy® legal in Switzerland?

Yes, Swissmedic has authorised the GLP-1 weight-loss injection class in Switzerland (liraglutide, semaglutide and tirzepatide), but they are prescription-only and Wegovy® became available only after Swissmedic approval. [4]

Is BPC-157 legal in Switzerland?

BPC-157 is not an authorised medicine in Switzerland and is treated as an unapproved research peptide that cannot be lawfully sold or marketed for human use; it is also a WADA-prohibited substance for athletes. [10]

Who regulates peptides in Switzerland?

Swissmedic, the Swiss Agency for Therapeutic Products, regulates peptides in Switzerland by authorising and classifying medicinal products before they can be marketed, with the Federal Office of Public Health overseeing the broader therapeutic-products framework. [2]

Sources

  1. SWI swissinfo.ch, What's behind the peptide boom and why it matters to Switzerland (retrieved 2026-09-23)
  2. Federal Office of Public Health (BAG), Simplified provision of List B medicinal products (retrieved 2026-09-23)
  3. Lexology, Life sciences: product regulation and liability in Switzerland (retrieved 2026-09-23)
  4. University Hospital Zurich (USZ), Drug therapy for overweight & obesity (retrieved 2026-09-23)
  5. SWI swissinfo.ch, Can new fat loss drugs help Switzerland fight rising obesity levels? (retrieved 2026-09-23)
  6. Swissmedic, Illegal drug imports / medicinal products from the Internet (retrieved 2026-09-23)
  7. Swissmedic, Trips abroad with medications (retrieved 2026-09-23)
  8. Swissmedic, Guideline on medicines and the Internet (retrieved 2026-09-23)
  9. The Swiss Times, Conditional and controlled introduction of weight loss injections (retrieved 2026-09-23)
  10. BSCG, BPC-157 Peptide: Benefits, Safety, Legal Status, and Research (retrieved 2026-09-23)

Last researched: 2026-09-23.

General information based on the sourced research above, not legal advice. Laws change and enforcement varies; for a specific situation in Switzerland, consult a licensed attorney or the national regulator.